Literature DB >> 15288486

Prognostic models including the Child-Pugh, MELD and Mayo risk scores--where are we and where should we go?

Erik Christensen1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15288486     DOI： 10.1016/j.jhep.2004.06.005

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  38 in total

1.  Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease.

Authors:  Hosny Salama; Abdel-Rahman N Zekri; Abeer A Bahnassy; Eman Medhat; Hanan A Halim; Ola S Ahmed; Ghada Mohamed; Sheren A Al Alim; Ghada M Sherif
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

Review 2.  Prioritization for liver transplantation.

Authors:  Evangelos Cholongitas; Giacomo Germani; Andrew K Burroughs
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

Review 3.  Liver transplantation organ allocation between Child and MELD.

Authors:  Ivo Graziadei
Journal:  Wien Med Wochenschr       Date:  2006-07

4.  Association of preoperative parameters with postoperative mortality and long-term survival after liver transplantation.

Authors:  Dionisios Vrochides; Mazzen Hassanain; Jeffrey Barkun; Jean Tchervenkov; Steven Paraskevas; Prosanto Chaudhury; Marcelo Cantarovich; Marc Deschenes; Phil Wong; Peter Ghali; Gabriel Chan; Peter Metrakos
Journal:  Can J Surg       Date:  2011-04       Impact factor: 2.089

5.  Medical Care of the Patient With Compensated Cirrhosis.

Authors:  Jorge L Herrera; Reynaldo Rodríguez
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-02

6.  Clinical presentation and survival of Asian and non-Asian patients with HCV-related hepatocellular carcinoma.

Authors:  Benjamin Yip; James M Wantuck; Lily H Kim; Robert J Wong; Aijaz Ahmed; Gabriel Garcia; Mindie H Nguyen
Journal:  Dig Dis Sci       Date:  2013-11-27       Impact factor: 3.199

7.  Living donor liver transplantation for high model for end-stage liver disease score: What have we learned?

Authors:  Hany Dabbous; Mohammad Sakr; Sara Abdelhakam; Iman Montasser; Mohamed Bahaa; Hany Said; Mahmoud El-Meteini
Journal:  World J Hepatol       Date:  2016-08-08

8.  The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study.

Authors:  Peter Jepsen; Hendrik Vilstrup; Peter Ott; Susanne Keiding; Per K Andersen; Niels Tygstrup
Journal:  BMC Gastroenterol       Date:  2009-06-30       Impact factor: 3.067

Review 9.  Role of stereotactic body radiotherapy in the management of primary hepatocellular carcinoma. Rationale, technique and results.

Authors:  H R Cárdenes
Journal:  Clin Transl Oncol       Date:  2009-05       Impact factor: 3.405

10.  Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.

Authors:  Daniel Gotthardt; Karl Heinz Weiss; Melanie Baumgärtner; Alexandra Zahn; Wolfgang Stremmel; Jan Schmidt; Thomas Bruckner; Peter Sauer
Journal:  BMC Gastroenterol       Date:  2009-09-25       Impact factor: 3.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.